Pathomechanisms of mutant proteins in charcot-marie-tooth disease

NeuroMolecular Medicine

Volumn 8, Issue 1-2, 2006, Pages 217-241

  Niemann, Axel ^a   Berger, Philipp ^a   Suter, Ueli ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Axon; Hereditary neuropathies; Myelin; Schwann cell

Indexed keywords

CONNEXIN 32; DYNAMIN II; GANGLIOSIDE INDUCED DIFFERENTIATION ASSOCIATED PROTEIN 1; GIGAXONIN; GLYCINE TRANSFER RNA LIGASE; GUANOSINE TRIPHOSPHATASE; HEAT SHOCK PROTEIN 27; KINESIN; LAMIN A; LAMIN C; MEMBRANE PROTEIN; MUTANT PROTEIN; MYELIN; MYOTUBULARIN RELATED PROTEIN 13; MYOTUBULARIN RELATED PROTEIN 2; NEUROFILAMENT LIGHT CHAIN; PERIAXIN; PERIPHERAL MYELIN PROTEIN 22; PROTEIN ZERO; PROTEOLIPID PROTEIN; RAB7 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EGR 2; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG;

CYTOSKELETON; DEMYELINATING NEUROPATHY; DEMYELINATION; ENDOCYTOSIS; ENDOSOME; GENE; GENE DOSAGE; GENE MUTATION; GENETIC DISORDER; HEREDITARY MOTOR SENSORY NEUROPATHY; HIGH MOBILITY GROUP BOX DOMAIN; LYSOSOME; MEMBRANE TRANSPORT; MITOCHONDRION; MYELIN SHEATH; N MYC DOWNSTREAM REGULATED GENE 1; NERVE FIBER; NEUROFILAMENT; NEUROPATHY; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; SCHWANN CELL;

EID: 33745268197     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:8:1-2:217     Document Type: Review

References (201)

1. Adlkofer K., Martini R., Aguzzi A., Zielasek J., Toyka K. V., and Suter U. (1995) Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat. Genet. 11, 274-280.
2. Adlkofer K., Naef R., and Suter U. (1997) Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele. J. Neurosci. Res. 49, 671-680.
3. Alexander C., Votruba M., Pesch U. E., et al. (2000) OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 26, 211-215.
4. Arroyo E. J. and Scherer S. S. (2000) On the molecular architecture of myelinated fibers. Histochem. Cell Biol. 113, 1-18.
5. Azzedine H., Bolino A., Taieb T., et al. (2003) Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am. J. Hum. Genet. 72, M41-M53.
6. Balice-Gordon R. J., Bone L. J., and Scherer S. S. (1998) Functional gap junctions in the schwann cell myelin sheath. J. Cell Biol. 142, 1095-1104.
7. Baxter R. V., Ben Othmane K., Rochelle J. M., et al. (2002) Ganglioside-induced differentiationassociated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat. Genet. 30, 21,22.
8. Benndorf R., Sun X., Gilmont R. R., et al. (2001) HSP22, a new member of the small heat shock protein superfamily interacts with mimic of phosphorylated HSP27 ((3D)HSP27). J. Biol. Chem. 276, 26,753-26,761.
9. Bennett C. L., Shirk A. J., Huynh H. M., et al. (2004) SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerve. Ann. Neurol. 55, 713-720.
10. Berger P., Berger I., Schaffitzel C., Tersar K., Volkmer B., and Suter U. (2006) Multi-level regulation of myotubularin-related protein-2 (mtmr2) phosphatase activity by myotubularin-related protein-13/set-binding factor-2 (MTMR13/SBF2). Hum. Mol. Genet. (Prepublication online).
11. Berger P., Bonneick S., Willi S., Wymann M., and Suter U. (2002) Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1. Hum. Mol. Genet. 11, 1569-1579.
12. Berger P., Schaffitzel C., Berger I., Ban N., and Suter U. (2003) Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module. Proc. Natl. Acad. Sci. USA 100, 12,177-12,182.
13. Berger P., Sirkowski E. E., Scherer S. S., and Suter U. (2004) Expression analysis of the N-Myc down-stream-regulated gene 1 indicates that myelinating Schwann cells are the primary disease target in hereditary motor and sensory neuropathy-Lom. Neurobiol. Dis. 17, 290-299.
14. Bolino A., Bolis A., Previtali S. C., et al. (2004) Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. J. Cell Biol. 167, 711-721.
15. Bolino A., Muglia M., Conforti F. L., et al. (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet. 25, 17-19.
16. Bolis A., Coviello S., Bussini S., et al. (2005) Loss of Mtmr2 phosphatase in Schwann cells but not in motor neurons causes Charcot-Marie-Tooth type 4B1 neuropathy with myelin outfoldings. J. Neurosci. 25, 8567-8577.
17. Bomont P., Cavalier L., Blondeau F., et al. (2000) The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonalneuropathy. Nat. Genet. 26, 370-374.
18. Bondurand N., Girard M., Pingault V., Lemort N., Dubourg O., and Goossens M. (2001 ) Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum. Mol. Genet. 10, 2783-2795.
19. Bonneick S., Boentert M., Berger P., et al. (2005) An animal model for Charcot-Marie-Tooth disease type 4B1 (CMT4B1). Hum. Mol. Genet. 14, 3685-3695.
20. Bossy-Wetzel E., Barsoum M. J., Godzik A., Schwarzenbacher R., and Lipton S. A. (2003) Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr. Opin. Cell Biol. 15, 706-716.
21. Brancolini C., Edomi P., Marzinotto S., and Schneider C. (2000) Exposure at the cell surface is required for gas3/PMP22 to regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases. Mol. Biol. Cell. 11, 2901-2914.
22. Brancolini C., Marzinotto S., Edomi P., et al. (1999) Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22. Mol. Biol. Cell 10, 2441-2459.
23. Britsch S., Goerich D. E., Riethmacher D., et al. (2001) The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 15, 66-78.
24. Brownlees J., Ackerley S., Grierson A. J., et al. (2002) Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum. Mol. Genet. 11, 2837-2844.
25. Buccione R., Orth J. D., and McNiven M. A. (2004) Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat. Rev. Mol. Cell Biol. 5, 647-657.
26. Cailloux F., Gauthier-Barichard F., Mimault C., et al. (2000) Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European network on brain dysmyelinating disease. Eur. J. Hum. Genet. 8, 837-845.
27. Carenini S., Neuberg D., Schachner M., Suter U., and Martini R. (1999) Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice. Glia 28, 256-264.
28. Chen H. and Chan D. C. (2004) Mitochondrial dynamics in mammals. Curr. Top. Dev. Biol. 59, 119-144.
29. Chen H., Chomyn A., and Chan D. C. (2005) Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J. Biol. Chem. 280, 26,185-26,192.
30. Chen H., Detmer S. A., Ewald A. J., Griffin E. E., Fraser S. E., and Chan D. C. (2003) Mitofusins Mfnl and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 160, 189-200.
31. Chies R., Nobbio L., Edomi P., Schenone A., Schneider C., and Brancolini C. (2003) Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22. J. Cell Sci. 116, 987-999.
32. Ching G. Y. and Liem R. K. (1993) Assembly of type IV neuronal intermediate filaments in nonneuronal cells in the absence of preexisting cytoplasmic intermediate filaments. J. Cell Biol. 122, 1323-1335.
33. Choudhury A., Dominguez M., Puri V., et al. (2002) Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. J. Clin. Invest. 109, 1541-1550.
34. Chubb J. R., Boyle S., Perry P., and Bickmore W. A. (2002) Chromatin motion is constrained by association with nuclear compartments in human cells. Curr. Biol. 12, 439-445.
35. Cipolat S., Martins de Brito O., Dal Zilio B., and Scorrano L. (2004) OPAl requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl. Acad. Sci. USA 101, 15,927-15,932.
36. Colby J., Nicholson R., Dickson K. M., et al. (2000) PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells. Neurobiol. Dis. 7, 561-573.
37. Court F. A., Sherman D. L., Pratt T., et al. (2004) Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature 431, 191-195.
38. Cuesta A., Pedrola L., Sevilla T., et al. (2002) The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat. Genet. 30, 22-25.
39. D'Urso D., Ehrhardt P., and Muller H. W. (1999) Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin. J. Neurosci. 19, 3396-3403.
40. D'Urso D., Prior R., Greiner-Petter R., Gabreels-Festen A. A., and Muller H. W. (1998) Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J. Neurosci. 18, 731-740.
41. Dang H., Li Z., Skolnik E. Y., and Fares H. (2004) Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans. Mol. Biol. Cell 15, 189-196.
42. Dawkins J. L., Hulme D. J., Brahmbhatt S. B., Auer-Grumbach M., and Nicholson G. A. (2001) Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat. Genet. 27, 309-312.
43. De Sandre-Giovannoli A., Chaouch M., Kozlov S., et al. (2002) Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am. J. Hum. Genet. 70, 726-736.
44. Dickson K. M., Bergeron J. J., Shames I., et al. (2002) Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for "gain-of-function" ER diseases. Proc. Natl. Acad. Sci. USA 99, 9852-9857.
45. Ding J., Liu J. J., Kowal A. S., et al. (2002) Microtubule-associated protein 1B: a neuronal binding partner for gigaxonin. J. Cell Biol. 158, 427-433.
46. Dunn W. A., Jr. (1990) Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J. Cell Biol. 110, 1923-1933.
47. Dytrych L., Sherman D. L., Gillespie C. S., and Brophy P. J. (1998) Two PDZ domain proteins encoded by the murine periaxin gene are the result of alternative intron retention and are differentially targeted in Schwann cells. J. Biol. Chem. 273, 5794-5800.
48. Edgar J. M. and Garbern J. (2004) The myelinated axon is dependent on the myelinating cell for support and maintenance: molecules involved. J. Neurosci. Res. 76, 593-598.
49. Evgrafov O. V., Mersiyanova I., Irobi J., et al. (2004) Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat. Genet. 36, 602-606.
50. Fabbretti E., Edomi P., Brancolini C., and Schneider C. (1995) Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev. 9, 1846-1856.
51. Feltri M. L. and Wrabetz L. (2005) Laminins and their receptors in Schwann cells and hereditary neuropathies. J. Peripher. Nerv. Syst. 10, 128-143.
52. Filbin M. T., Zhang K., Li W., and Gao Y. (1999) Characterization of the effect on adhesion of different mutations in myelin P0 protein. Ann. N. Y. Acad. Sci. 883, 160-167.
53. Fortun J., Dunn W. A., Jr., Joy S., Li J., and Notterpek L. (2003) Emerging role for autophagy in the removal of aggresomes in Schwann cells. J. Neurosci. 23, 10,672-10,680.
54. Fortun J., Li J., Go J., Fenstermaker A., Fletcher B. S., and Notterpek L. (2005) Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model. J. Neurochem. 92, 1531-1541.
55. Garbern J. Y., Cambi F., Tang X. M., et al. (1997) Proteolipid protein is necessary in peripheral as well as central myelin. Neuron 19, 205-218.
56. Garcia M. L., Lobsiger C. S., Shah S. B., et al. (2003) NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth. J. Cell Biol. 163, 1011-1020.
57. Gaullier J. M., Simonsen A., D'Arrigo A., Bremnes B., Stenmark H., and Aasland R. (1998) FYVE fingers bind PtdIns(3)P. Nature 394, 432, 433.
58. Giambonini-Brugnoli G., Buchstaller J., Sommer L., Suter U., and Mantei N. (2005) Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation. Neurobiol. Dis. 18, 656-668.
59. Giese K. P., Martini R., Lemke G., Soriano P., and Schachner M. (1992) Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71, 565-576.
60. Gillespie C. S., Sherman D. L., Fleetwood-Walker S. M., et al. (2000) Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 26, 523-531.
61. Gutierrez M. G., Munafo D. B., Beron W., and Colombo M. I. (2004) Rab7 is required for the normal progression of the autophagic pathway in mammalian cells. J. Cell Sci. 117, 2687-2697.
62. Hagedorn L., Suter U., and Sommer L. (1999) P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors. Development 126, 3781-3794.
63. Hasse B., Bosse F., Hanenberg H., and Muller H. W. (2004) Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions. Mol. Cell Neurosci. 27, 370-378.
64. Hirokawa N. and Takemura R. (2005) Molecular motors and mechanisms of directional transport in neurons. Nat. Rev. Neurosci. 6, 201-214.
65. Houlden H., Girard M., Cockerell C., et al. (2004) Connexin 32 promoter P2 mutations: a mechanism of peripheral nerve dysfunction. Ann. Neurol. 56, 730-734.
66. Howard J. and Hyman A. A. (2003) Dynamics and mechanics of the microtubuleplus end. Nature 422, 753-758.
67. Hunter M., Angelicheva D., Tournev I., et al. (2005) NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24. Biochem. Biophys. Res. Commun. 332, 982-992.
68. Hunter M., Bernard R., Freitas E., et al. (2003) Mutation screening of the N-myc downstream-regulated gene 1 (NDRG1) in patients with Charcot-Marie-Tooth Disease. Hum. Mutat. 22, 129-135.
69. Hutchison C. J. and Worman H. J. (2004) A-type lamins: guardians of the soma? Nat. Cell Biol. 6, 1062-1067.
70. Huxley C., Passage E., Manson A., et al. (1996) Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. Mol. Genet. 5, 563-569.
71. Inoue K., Shilo K., Boerkoel C. F., et al. (2002) Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg-Hirschsprung disease: phenotypes linked by SOX10 mutation. Ann. Neurol. 52, 836-842.
72. Irobi J., Van Impe K., Seeman P., et al. (2004) Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat. Genet. 36, 597-601.
73. Isaacs A. M., Jeans A., Oliver P. L., et al. (2002) Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated peripheral neuropathy. Mol. Cell Neurosci. 21, 114-125.
74. Jessen K. R. and Mirsky R. (1999) Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci. 22, 402-410.
75. Jessen K. R. and Mirsky R. (2002) Signals that determine Schwann cell identity. J. Anal. 200, 367-376.
76. Jetten A. M. and Suter U. (2000) The peripheral myelin protein 22 and epithelial membrane protein family. Prog. Nucleic Acid Res. Mol. Biol. 64, 97-129.
77. Jolliffe C. N., Harvey K. F., Haines B. P., Parasivam G., and Kumar S. (2000) Identification of multiple proteins expressed in murine embryos as binding partners for the WW domains of the ubiquitin-protein ligase Nedd4. Biochem. J. 351(3), 557-565.
78. Kaul R., Gao G. P., Balamurugan K., and Matalon R. (1993) Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavandisease. Nat. Genet. 5, 118-123.
79. Kim J., Lo L., Dormand E., and Anderson D. J. (2003) SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron 38, 17-31.
80. Koshiba T., Detmer S. A., Kaiser J. T., Chen H., McCaffery J. M., and Chan D. C. (2004) Structural basis of mitochondrial tethering by mitofusin complexes. Science 305, 858-862.
81. Kuhlenbaumer G., Young P., Oberwittler C., et al. (2002) Giant axonal neuropathy (GAN): case report and two novel mutations in the gigaxonin gene. Neurology 58, 1273-1276.
82. LaMonte B. H., Wallace K. E., Holloway B. A., et al. (2002) Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34, 715-727.
83. Laporte J., Hu L. J., Kretz C., et al. (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet. 13, 175-182.
84. Lariviere R. C. and Julien J. P. (2004) Functions of intermediate filaments in neuronal development and disease. J. Neurobiol. 58, 131-148.
85. Le N., Nagarajan R., Wang J. Y., Araki T., Schmidt R. E., and Milbrandt J. (2005a) Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc. Natl. Acad. Sci. USA 102, 2596-2601.
86. Le N., Nagarajan R., Wang J. Y., et al. (2005b) Nab proteins are essential for peripheral nervous system myelination. Nat. Neurosci. 8, 932-940.
87. Leblanc S. E., Srinivasan R., Ferri C., et al. (2005) Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelination. J. Neurochem. 93, 737-748.
88. Lee G. J., Roseman A. M., Saibil H. R., and Vierling E. (1997) A small heat shock protein stably binds heat-denatured model substrates and can maintain a substrate in a folding-competent state. EMBO J. 16, 659-671.
89. Lee M. K., Xu Z., Wong P. C., and Cleveland D. W. (1993) Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol. 122, 1337-1350.
90. Liu N., Yamauchi J., and Shooter E. M. (2004) Recessive, but not dominant, mutations in peripheral myelin protein 22 gene show unique patterns of aggregation and intracellular trafficking. Neurobiol. Dis. 17, 300-309.
91. Ludes-Meyers J. H., Kil H., Bednarek A. K., Drake J., Bedford M. T., and Aldaz C. M. (2004) WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins. Oncogene 23, 5049-5055.
92. Lupski J. R. and Chance P. F. (2005) Hereditary motor and sensory neuropathies involving altered dosage or mutation of PMP22: the CMT1A duplication and HNPP deletion, In: Dyck P. J. and Thomas P. K. (eds). Peripheral Neuropathies, Philadelphia: Elsevier Saunders, Vol. 2. pp. 1659-1680.
93. Magyar J. P., Martini R., Ruelicke T., et al. (1996) Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16, 5351-5360.
94. Mahadevan A., Santosh V., Gayatri N., et al. (2000) Infantile neuroaxonal dystrophy and giant axonal neuropathy - overlap diseases of neuronal cytoskeletal elements in childhood? Clin. Neuropathol. 19, 221-229.
95. Martini R. (2001) The effect of myelinating Schwann cells on axons. Muscle Nerve 24, 456-466.
96. Martini R., Zielasek J., Toyka K. V., Giese K. P., and Schachner M. (1995) Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat. Genet. 11, 281-286.
97. McNiven M. A. (2005) Dynamin in disease. Nat. Genet. 37, 215, 216.
98. McNiven M. A., Baldassarre M., and Buccione R. (2004) The role of dynamin in the assembly and function of podosomes and invadopodia. Front. Biosci. 9, 1944-1953.
99. Meggouh F., de Visser M., Arts W. F., De Coo R. I., van Schaik I. N., and Baas F. (2005) Early onset neuropathy in a compound form of Charcot-Marie-Tooth disease. Ann. Neurol. 57, 589-591.
100. Meier C., Dermietzel R., Davidson K. G., Yasumura T., and Rash J. E. (2004) Connexin32-containing gap junctions in Schwann cells at the internodal zone of partial myelin compaction and in Schmidt-Lanterman incisures. J. Neurosci. 24, 3186-3198.
101. Michailov G. V., Sereda M. W., Brinkmann B. G., et al. (2004) Axonal neuregulin-1 regulates myelin sheath thickness. Science 304, 700-703.
102. Mollaaghababa R. and Pavan W. J. (2003) The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia. Oncogens 22, 3024-3034.
103. Moriwaki Y., Begum N. A., Kobayashi M., Matsumoto M., Toyoshima K., and Seya T. (2001) Mycobacterium bovis Bacillus Calmette-Guerin and its cell wall complex induce a novel lysosomal membrane protein, SIMPLE, that bridges the missing link between lipopolysaccharide and p53-inducible gene, LITAF(PIG7), and estrogen-inducible gene, EET-1. J. Biol. Chem. 276, 23,065-23,076.
104. Mounkes L. and Stewart C. L. (2004) Structural organization and functions of the nucleus in development, aging, and disease. Curr. Top. Dev. Biol. 61, 191-228.
105. Muller H. W. (2000) Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: new facts and hypotheses. Glia 29, 182-185.
106. Naef R., Adlkofer K., Lescher B., and Suter U. (1997) Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol. Cell Neurosci. 9, 13-25.
107. Naef R. and Suter U. (1999) Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol. Dis. 6, 1-14.
108. Nagarajan R., Svaren J., Le N., Araki T., Watson M., and Milbrandt J. (2001) EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 30, 355-368.
109. Nangaku M., Sato-Yoshitake R., Okada Y., et al. (1994) KIF1B, a novel microtubule plus end-directed monomeric motor protein for transport of mitochondria. Cell 79, 1209-1220.
110. Nelis E., Erdem S., Van Den Bergh P. Y., et al. (2002) Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy. Neurology 59, 1865-1872.
111. Neuberg D. H., Sancho S., and Suter U. (1999) Altered molecular architecture of peripheral nerves in mice lacking the peripheral myelin protein 22 or connexin32. J. Neurosci. Res. 58, 612-623.
112. Neuspiel M., Zunino R., Gangaraju S., Rippstein P., and McBride H. (2005) Activated mitofusin 2 signals mitochondrial fusion, interferes with bax activation, and reduces susceptibility to radical induced depolarization. J. Biol. Chem. 280, 25,060-25,070.
113. Niemann A., Rueegg M., La Padula V., Schenone A., and Suter U. (2005) Ganglioside-induced differentiation associated protein 1 (GDAP1) is a regulator of the mitochondrial network - new implications for Charcot-Marie-Tooth disease. J. Cell Biol. 170, 1067-1078.
114. Niemann S., Sereda M. W., Suter U., Griffiths I. R., and Nave K. A. (2000) Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22. J. Neurosci. 20, 4120-4128.
115. Notterpek L., Roux K. J., Amici S. A., Yazdanpour A., Rahner C., and Fletcher B. S. (2001) Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia. Proc. Natl. Acad. Sci. USA 98, 14,404-14,409.
116. Notterpek L., Ryan M. C., Tobler A. R., and Shooter E. M. (1999) PMP22 accumulation in aggresomes: implications for CMT1A pathology. Neurobiol. Dis. 6, 450-460.
117. Notterpek L., Shooter E. M., and Snipes G. J. (1997) Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy. J. Neurosci. 17, 4190-4200.
118. Okuda T., Higashi Y., Kokame K., Tanaka C., Kondoh H., and Miyata T. (2004) Ndrgl-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves. Mol. Cell Biol. 24, 3949-3956.
119. Olichon A., Baricault L., Gas N., et al. (2003) Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J. Biol. Chem. 278, 7743-7746.
120. Orth J. D. and McNiven M. A. (2003) Dynamin at the actin-membrane interface. Curr. Opin. Cell Biol. 15, 31-39.
121. Paratore C., Goerich D. E., Suter U., Wegner M., and Sommer L. (2001) Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development 128, 3949-3961.
122. Pareek S., Notterpek L., Snipes G. J., et al. (1997) Neurons promote the translocation of peripheral myelin protein 22 into myelin. J. Neurosci. 17, 7754-7762.
123. Pareek S., Suter U., Snipes G. J., Welcher A. A., Shooter E. M., and Murphy R. A. (1993) Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells. J. Biol. Chem. 268, 10,372-10,379.
124. Parkinson D. B., Bhaskaran A., Droggiti A., et al. (2004) Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death. J. Cell Biol. 164, 385-394.
125. Passage E., Norreel J. C., Noack-Fraissignes P., et al. (2004) Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat. Med. 10, 396-401.
126. Pedrola L., Espert A., Wu X., Claramunt R., Shy M. E., and Palau F. (2005) GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria. Hum. Mol. Genet. 14, 1087-1094.
127. Peirano R. I., Goerich D. E., Riethmacher D., and Wegner M. (2000) Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol. Cell Biol. 20, 3198-3209.
128. Peirano R. I. and Wegner M. (2000) The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences. Nucleic Acids Res. 28, 3047-3055.
129. Perez-Olle R., Jones S. T., and Liem R. K. (2004) Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models. Hum. Mol. Genet. 13, 2207-2220.
130. Perez-Olle R., Leung C. L., and Liem R. K. (2002) Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation. J. Cell Sci. 115, 4937-4946.
131. Perez-Olle R., Lopez-Toledano M. A., Goryunov D., et al. (2005) Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport. J Neurochem. 93, 861-874.
132. Perfettini J. L., Roumier T., and Kroemer G. (2005) Mitochondrial fusion and fission in the control of apoptosis. Trends Cell Biol. 15, 179-183.
133. Pich S., Bach D., Briones P., et al. (2005) The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum. Mol. Genet. 14, 1405-1415.
134. Pintard L., Willems A., and Peter M. (2004) Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family. EMBO J. 23, 1681-1687.
135. Poliak S. and Peles E. (2003) The local differentiation of myelinated axons at nodes of Ranvier. Nat. Rev. Neurosci. 4, 968-980.
136. Pornillos O., Alam S. L., Davis D. R., and Sundquist W. I. (2002) Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat. Struct. Biol. 9, 812-817.
137. Praefcke G. J. and McMahon H. T. (2004) The dynamin superfamily: universal membrane tubulation and fission molecules? Nat. Rev. Mol. Cell Biol. 5, 133-147.
138. Previtali S. C., Quattrini A., Pasolini M., et al. (2000) Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice. J. Cell Biol. 151, 1035-1046.
139. Previtali S. C., Zerega B., Sherman D. L., et al. (2003) Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve. Hum. Mol. Genet. 12, 1713-1723.
140. Puls I., Jonnakuty C., LaMonte B. H., et al. (2003) Mutant dynactin in motor neuron disease. Nat. Genet. 33, 455-456.
141. Rappoport J. Z. and Simon S. M. (2003) Real-time analysis of clathrin-mediated endocytosis during cell migration. J. Cell Sci. 116, 847-855.
142. Robinson F. L. and Dixon J. E. (2005) The phosphoinositide 3-phosphatase MTMR2 associates with MTMR13, a novel membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-tooth disease. J. Biol. Chem. 280, 31,699-31,707.
143. Rojo M., Legros P., Chateau D., and Lombes A. (2002) Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J. Cell Sci. 115, 1663-1674.
144. Roux K. J., Amici S. A., Fletcher B. S., and Notterpek L. (2005) Modulation of epithelial morphology, monolayer permeability, and cell migration by growth arrest specific 3/peripheral myelin protein 22. Mol. Biol. Cell 16, 1142-1151.
145. Roux K. J., Amici S. A., and Notterpek L. (2004) The temporospatial expression of peripheral myelin protein 22 at the developing blood-nerve and blood-brain barriers. J. Comp. Neurol. 474, 578-588.
146. Roy S. and Rauk A. (2005) Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity. Med. Hypotheses 65, 123-137.
147. Ryan M. C., Shooter E. M., and Notterpek L. (2002) Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiol. Dis. 10, 109-118.
148. Saifi G. M., Szigeti K., Snipes G. J., Garcia C. A., and Lupski J. R. (2003) Molecular mechanisms, diagnosis, and rational approaches to management of and therapy for Charcot-Marie-Tooth disease and related peripheral neuropathies. J. Investig. Med. 51, 261-283.
149. Saifi G. M., Szigeti K., Wiszniewski W., et al. (2005) SIMPLE mutations in Charcot-Marie-Tooth disease and the potential role of its protein product in protein degradation. Hum. Mutat. 25, 372-383.
150. Saito M., Hayashi Y., Suzuki T., Tanaka H., Hozumi I., and Tsuji S. (1997) Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A. Neurology 49, 1630-1635.
151. Salzer J. L. (2003) Polarized domains of myelinated axons. Neuron 40, 297-318.
152. Sancho S., Young P., and Suter U. (2001) Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A. Brain 124, 2177-2187.
153. Santel A. and Fuller M. T. (2001) Control of mitochondrial morphology by a human mitofusin. J. Cell Sci. 114, 867-874.
154. Scherer S. S. and Arroyo E. J. (2002) Recent progress on the molecular organization of myelinated axons. J. Peripher. Nerv. Syst. 7, 1-12.
155. Scherer S. and Paul D. L. (2004) The Connexin32 and Connexin29 Genes, In: Lazzarini R. A. (ed). Myelin Biology and Disorders. Elsevier Academic, San Diego, pp. 599-608.
156. Scherer S. S., Xu Y. T., Messing A., Willecke K., Fischbeck K. H., and Jeng L. J. (2005) Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice. J. Neurosci. 25, 1550-1559.
157. Senderek J., Bergmann C., Stendel C., et al. (2003a) Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy. Am. J. Hum. Genet. 73, 1106-1119.
158. Senderek J., Bergmann C., Weber S., et al. (2003b) Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum. Mol. Genet. 12, 349-356.
159. Sereda M., Griffiths I., Puhlhofer A., et al. (1996) A rat transgenic model for Charcot-Marie-Tooth disease. Neuron 16, 1049-1060.
160. Sereda M. W., Meyer zu Horste G., Suter U., Uzma N., and Nave K. A. (2003) Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat. Med. 9, 1533-1537.
161. Shames I., Fraser A., Colby J., Orfali W., and Snipes G. J. (2003) Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases. J. Neuropathol. Exp. Neurol. 62, 751-764.
162. Shapiro L., Doyle J. P., Hensley P., Colman D. R., and Hendrickson W. A. (1996) Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 17, 435-449.
163. Sherman D. L., Fabrizi C., Gillespie C. S., and Brophy P. J. (2001) Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 30, 677-687.
164. Shisheva A., Rusin B., Ikonomov O. C., DeMarco C., and Sbrissa D. (2001) Localization and insulin-regulated relocation of phosphoinositide 5-kinase PIKfyve in 3T3-L1 adipocytes. J. Biol. Chem. 276, 11,859-11,869.
165. Shy M. E. (2004) Charcot-Marie-Tooth disease: an update. Curr. Opin. Neurol. 17, 579-585.
166. Shy M. E., Hobson G., Jain M., et al. (2003) Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy. Ann. Neurol. 53, 354-365.
167. Sivakumar K., Kyriakides T., Puls I., et al. (2005) Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain. 128, 2304-2314.
168. Snipes G. J., Suter U., Welcher A. A., and Shooter E. M. (1992) Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J. Cell Biol. 117, 225-238.
169. Southwood C. M., Garbern J., Jiang W., and Gow A. (2002) The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36, 585-596.
170. Stogios P. J. and Prive G. G. (2004) The BACK domain in BTB-kelch proteins. Trends Biochem. Sci. 29, 634-637.
171. Straub B. K., Boda J., Kuhn C., et al. (2003) A novel cell-cell junction system: the cortex adhaerens mosaic of lens fiber cells. J. Cell Sci. 116, 4985-4995.
172. Sugiki T., Taketomi Y., Kikuchi-Yanoshita R., Murakami M., and Kudo I. (2004) Association of N-myc down-regulated gene 1 with heat-shock cognate protein 70 in mast cells. Biol. Pharm. Bull. 27, 628-633.
173. Sun X., Fontaine J. M., Rest J. S., Shelden E. A., Welsh M. J., and Benndorf R. (2004) Interaction of human HSP22 (HSPB8) with other small heat shock proteins. J. Biol. Chem. 279, 2394-2402.
174. Sun Y. and MacRae T. H. (2005) The small heat shock proteins and their role in human disease. FEBS J. 272, 2613-2627.
175. Suter U. (2004) PMP22 gene, In: Lazzarini R. A. (ed).Myelin Biology and Disorders. Elsevier Academic, San Diego, pp. 547-564.
176. Suter U., Moskow J. J., Welcher A. A., et al. (1992a) A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc. Natl. Acad. Sci. USA 89, 4382-4386.
177. Suter U. and Scherer S. S. (2003) Disease mechanisms in inherited neuropathies. Nat. Rev. Neurosci. 4, 714-726.
178. Suter U. and Snipes G. J. (1995) Biology and genetics of hereditary motor and sensory neuropathies. Annu. Rev. Neurosci. 18, 45-75.
179. Suter U., Welcher A. A., Ozcelik T., et al. (1992b) Trembler mouse carries a point mutation in a myelin gene. Nature 356, 241-244.
180. Takashima H., Boerkoel C. F., De Jonghe P., et al. (2002) Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann. Neurol. 51, 709-715.
181. Taylor V., Zgraggen C., Naef R., and Suter U. (2000) Membrane topology of peripheral myelin protein 22. J. Neurosci. Res. 62, 15-27.
182. Tazir M., Azzedine H., Assami S., et al. (2004) Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C. Brain 127, 154-163.
183. Thompson H. M., Cao H., Chen J., Euteneuer U., and McNiven M. A. (2004) Dynamin 2 binds gamma-tubulin and participates in centrosome cohesion. Nat. Cell Biol. 6, 335-342.
184. Tobler A. R., Liu N., Mueller L., and Shooter E. M. (2002) Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22. Proc. Natl. Acad. Sci. USA 99, 483-488.
185. Tobler A. R., Notterpek L., Naef R., Taylor V., Suter U., and Shooter E. M. (1999) Transport of trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction. J. Neurosci. 19, 2027-2036.
186. Topilko P., Schneider-Maunoury S., Levi G., et al. (1994) Krox-20 controls myelination in the peripheral nervous system. Nature 371, 796-799.
187. Vaurs-Barriere C., Wong K., Weibel T. D., et al. (2003) Insertion of mutant proteolipid protein results in missorting of myelin proteins. Ann. Neurol. 54, 769-780.
188. Verhoeven K., De Jonghe P., Coen K., et al. (2003) Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am. J. Hum. Genet. 72, 722-727.
189. Vonderheit A. and Helenius A. (2005) Rab7 associates with early endosomes to mediate sorting and transport of Semliki forest virus to late endosomes. PLoS Biol. 3, e233.
190. Wagner O. I., Ascano J., Tokito M., Leterrier J. F., Janmey P. A., and Holzbaur E. L. (2004) The interaction of neurofilaments with the microtubule motor cytoplasmic dynein. Mol. Biol. Cell 15, 5092-5100.
191. Walker D. M., Urbe S., Dove S. K., Tenza D., Raposo G., and Clague M. J. (2001) Characterization of MTMR3. an inositol lipid 3-phosphatase with novel substrate specificity. Curr. Biol. 11, 1600-1605.
192. Warner L. E., Mancias P., Butler I. J., et al. (1998) Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat. Genet. 18, 382-384.
193. Warner L. E., Svaren J., Milbrandt J., and Lupski J. R. (1999) Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. Hum. Mol. Genet. 8, 1245-1251.
194. Wishart M. J. and Dixon J. E. (2002) PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease. Phosphatase and tensin homolog deleted on chromosome ten. Trends Cell Biol. 12, 579-585.
195. Woese C. R., Olsen G. J., Ibba M., and Soll D. (2000) Aminoacyl-tRNA synthetases, the genetic code, and the evolutionary process. Microbiol. Mol. Biol. Rev. 64, 202-236.
196. Xia C. H., Roberts E. A., Her L. S., et al. (2003) Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J. Cell Biol. 161, 55-66.
197. Xu Z., Marszalek J. R., Lee M. K., et al. (1996) Subunit composition of neurofilaments specifies axonal diameter. J. Cell Biol. 133, 1061-1069.
198. Yin X., Kidd G. J., Wrabetz L., Feltri M. L., Messing A., and Trapp B. D. (2000) Schwann cell myelination requires timely and precise targeting of P(0) protein. J. Cell Biol. 148, 1009-1020.
199. Zhao C., Takita J., Tanaka Y., et al. (2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105, 587-597.
200. Züchner S., Mersiyanova I. V., Muglia M., et al. (2004) Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36, 449-451.
201. Zuchner S., Noureddine M., Kennerson M., et al. (2005) Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat. Genet. 37, 289-294.